Good Health Can’t Wait.

Standalone Financial Statements Annual Report 2014 - 15
CASH FLOW STATEMENT (CONTINUED)
(All amounts in Indian Rupees millions, except share data and where otherwise stated)
PARTICULARS
FOR THE YEAR ENDED
31 MARCH 2015
FOR THE YEAR ENDED
31 MARCH 2014
CASH FLOWS FROM / (USED IN) FINANCING ACTIVITIES
Proceeds from issuance of share capital 5 2
Redemption of 9.25% redeemable non-convertible debentures of ` 5/- each - (5,078)
Proceeds from long term borrowings - 9,089
Repayment of short term borrowings (21,220) (35,230)
Proceeds from short term borrowings 27,370 35,306
Interest paid (687) (828)
Dividend paid (including dividend distribution tax) (3,574) (2,979)
Net cash from financing activities 1,894 282
Net increase / (decrease) in cash and cash equivalents (410) 529
Cash and cash equivalents at the beginning of the year (refer note 2.13) 1,156 561
Effect of foreign exchange gain / (loss) on cash and cash equivalents (146) 66
Cash and cash equivalents at the end of the year (refer note 2.13) 600 1,156
Notes to the cash flow statement:
Cash and cash equivalents at the end of the year (refer note 2.13) 600 1,156
Other bank balances (refer note 2.13) 8,414 5,495
Cash and bank balances at the end of the year (refer note 2.13) 9,014 6,651
The accompanying notes are an integral part of financial statements
As per our report of even date attached
for B S R & Co. LLP
Chartered Accountants
for and on behalf of the Board of Directors of Dr. Reddy’s Laboratories Limited
Firm Registration No.: 101248W/W-100022
Supreet Sachdev
Partner K Satish Reddy Chairman
Membership No.: 205385 G V Prasad Co-Chairman & Chief Executive Officer
Place : Hyderabad Saumen Chakraborty President & Chief Financial Officer
Date : 12 May 2015 Sandeep Poddar Company Secretary
117